Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
Bilen MA, Vo BT, Liu Y, Greenwald R, Davarpanah AH, McGuire D, Shiradkar R, Li L, Midya A, Nazha B, Brown JT, Williams S, Session W, Russler G, Caulfield S, Joshi SS, Narayan VM, Filson CP, Ogan K, Kucuk O, Carthon BC, Del Balzo L, Cohen A, Boyanton A, Prokhnevska N, Cardenas MA, Sobierajska E, Jansen CS, Patil DH, Nicaise E, Osunkoya AO, Kissick HT, Master VA.
Bilen MA, et al. Among authors: midya a.
Nat Cancer. 2025 Mar;6(3):432-444. doi: 10.1038/s43018-025-00922-5. Epub 2025 Feb 27.
Nat Cancer. 2025.
PMID: 40016487
Clinical Trial.